Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL.
Saved in:
| Title: | Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. |
|---|---|
| Authors: | Middleton O; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Cosimo E; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Dobbin E; Department of Haematology, Western General Hospital, Edinburgh, UK., McCaig AM; 1] Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK [2] Department of Haematology, Royal Alexandra Hospital, Paisley, UK., Clarke C; GlaxoSmithKline UK Ltd, Stockley Park West, Uxbridge, Middlesex, UK., Brant AM; GlaxoSmithKline UK Ltd, Stockley Park West, Uxbridge, Middlesex, UK., Leach MT; Department of Haematology, West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, UK., Michie AM; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Wheadon H; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. |
| Source: | Leukemia [Leukemia] 2015 Jan; Vol. 29 (1), pp. 107-14. Date of Electronic Publication: 2014 May 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
